Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question

被引:14
作者
Letitia Adela Maria Streba [1 ]
Cristin Constantin Vere [2 ,3 ]
Ion Rogoveanu [2 ,3 ]
Costin Teodor Streba [2 ]
机构
[1] Internal Medicine,Medical Semiology,University of Medicine and Pharmacy of Craiova
[2] Research Center of Gastroenterology and Hepatology of Craiova,University of Medicine and Pharmacy of Craiova
[3] Internal Medicine,Gastroenterology,University of Medicine and Pharmacy of Craiova
关键词
Diabetes mellitus; Hepatocellular carcinoma; Metabolic syndrome; Non-alcoholic fatty liver disease; Obesity;
D O I
暂无
中图分类号
R575 [肝及胆疾病]; R735.7 [肝肿瘤];
学科分类号
1002 ; 100201 ; 100214 ;
摘要
Non-alcoholic liver disease(NAFLD) defines liver abnormalities ranging from simple steatosis to nonalcoholic steatohepatitis with or without cirrhosis development, occurring in the absence of significant alcohol consumption, use of teratogenic medication, or hereditary disorders.The association between NAFLD and metabolic syndrome is well documented and widely recognized.Obesity, type 2 diabetes mellitus(T2DM), and dyslipidemia are the most common metabolic risk factors associated with NAFLD.Among the components of metabolic syndrome, current evidence strongly indicates obesity and diabetes as hepatocellular carcinoma(HCC) risk factors.There is also growing evidence that suggests an increased risk of HCC in NAFLD patients, even surpassing other etiologies in some high-income countries.Epidemiologic data demonstrate a parallel rise in prevalence of obesity, diabetes, NAFLD, and HCC.As obesity and its related diseases have steadily afflicted larger populations, HCC incidence is expected to increase in the future.Pathophysiologic mechanisms that underlie NAFLD development and subsequent progression to nonalcoholic steatohepatitis and cirrhosis(insulin resistance and hyperinsulinemia, oxidative stress, hepatic stellate cell activation, cytokine/adipocytokine signaling pathways, and genetic and environmental factors) appear to play a significant role in the development of NAFLD-related HCC.However, a comprehensive view of molecular mechanisms linking obesity, T2 DM, and NAFLD-related HCC, as well as the exact sequence of molecular events, is still not understood in its entirety.Good-quality data are still necessary, and efforts should continue towards better understanding the underlying carcinogenic mechanisms of NAFLD-related HCC.In this paper, we aimed to centralize the most important links supporting these relationships, focusing on obesity, T2 DM, and NAFLD-related HCC, as well as point out the major gaps in knowledge regarding the underlying molecular mechanisms behind them.
引用
收藏
页码:4103 / 4110
页数:8
相关论文
共 56 条
  • [1] Targeting the insulin-like growth factor pathway in hepatocellular carcinoma[J]. Mónica Enguita-Germán,Puri Fortes.World Journal of Hepatology. 2014(10)
  • [2] Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
    Paola Dongiovanni
    Stefano Romeo
    Luca Valenti
    [J]. World Journal of Gastroenterology, 2014, 20 (36) : 12945 - 12955
  • [3] Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?[J]. Antonella Scalerar,Giovanni Tarantino.World Journal of Gastroenterology. 2014(28)
  • [4] Obesity and non-alcoholic fatty liver disease: Disparate associations among asian populations
    Robert J Wong
    Aijaz Ahmed
    [J]. World Journal of Hepatology, 2014, (05) : 263 - 273
  • [5] What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?[J]. Giovanni Tarantino,Carmine Finelli.World Journal of Gastroenterology. 2013(22)
  • [6] Obesity and cholangiocarcinoma[J]. Mansour A Parsi.World Journal of Gastroenterology. 2013(04)
  • [7] Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection[J]. Chao-Hung Hung,Jing-Houng Wang,Tsung-Hui Hu,Chien-Hung Chen,Kuo-Chin Chang,Yi-Hao Yen,YuanHung Kuo,Ming-Chao Tsai,Chuan-Mo Lee.World Journal of Gastroenterology. 2010(18)
  • [8] Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma[J] . Y.-L. Liu,G.L. Patman,J.B.S. Leathart,A.-C. Piguet,A.D. Burt,J.-F. Dufour,C.P. Day,A.K. Daly,H.L. Reeves,Q.M. Anstee.Journal of Hepatology . 2014
  • [9] Development of Hepatocellular Carcinoma in a Murine Model of Nonalcoholic Steatohepatitis Induced by Use of a High-Fat/Fructose Diet and Sedentary Lifestyle[J] . Joanna K. Dowman,Laurence J. Hopkins,Gary M. Reynolds,Nikolaos Nikolaou,Matthew J. Armstrong,Jean C. Shaw,Diarmaid D. Houlihan,Patricia F. Lalor,Jeremy W. Tomlinson,Stefan G. Hübscher,Philip N. Newsome.The American Journal of Pathology . 2014
  • [10] A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
    Fujii, Masato
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Honda, Yutaka
    Kawauchi, Yusuke
    Suzuki, Kenji
    Arumugam, Somasundaram
    Watanabe, Kenichi
    Ichida, Takafumi
    Asakura, Hitoshi
    Yoneyama, Hiroyuki
    [J]. MEDICAL MOLECULAR MORPHOLOGY, 2013, 46 (03) : 141 - 152